Medwise Overseas Private Limited — Rifampicin Exporter Profile
Indian Pharmaceutical Exporter · #9 for Rifampicin · $750.0K export value · DGFT Verified
Medwise Overseas Private Limited is the #9 Indian exporter of Rifampicin with $750.0K in export value and 15 verified shipments. Medwise Overseas Private Limited holds a 0.1% market share in Rifampicin exports across 4 countries. The company exports 19 pharmaceutical products worth $4.4M across 10 therapeutic categories.
Medwise Overseas Private Limited — Rifampicin Export Profile: Buyers & Destinations
Where Does Medwise Overseas Private Limited Export Rifampicin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TAJIKISTAN | $225.7K | 8 | 52.7% |
| SOUTH AFRICA | $150.0K | 3 | 35.0% |
| BOTSWANA | $28.4K | 1 | 6.6% |
| GUYANA | $24.0K | 3 | 5.6% |
Medwise Overseas Private Limited exports Rifampicin to 4 countries. The largest destination is TAJIKISTAN accounting for 52.7% of Medwise Overseas Private Limited's Rifampicin shipments, followed by SOUTH AFRICA (35.0%) and BOTSWANA (6.6%). These destinations reflect Medwise Overseas Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rifampicin from Medwise Overseas Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TO. | SOUTH AFRICA | $150.0K | 3 |
| TO" | BOTSWANA | $28.4K | 1 |
Medwise Overseas Private Limited supplies Rifampicin to 2 buyers globally. The largest buyer is TO. (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rifampicin Export Value and How Much Does Medwise Overseas Private Limited Contribute?
India exported $121.8M worth of Rifampicin through 3,913 shipments from 175 suppliers to 162 countries, serving 780 buyers globally. Medwise Overseas Private Limited contributes $750.0K to this total, accounting for 0.1% of India's Rifampicin exports. Medwise Overseas Private Limited ships Rifampicin to 4 countries through 2 buyers.
What Is the Average Shipment Value for Medwise Overseas Private Limited's Rifampicin Exports?
Medwise Overseas Private Limited's average Rifampicin shipment value is $50.0K per consignment, based on 15 shipments totaling $750.0K. The largest destination is TAJIKISTAN (52.7% of Medwise Overseas Private Limited's Rifampicin exports).
How Does Medwise Overseas Private Limited Compare to Other Indian Rifampicin Exporters?
Medwise Overseas Private Limited ranks #9 among 175 Indian Rifampicin exporters with a 0.1% market share. The top 3 exporters are MACLEODS PHARMACEUTICALS LTD ($64.0M), MACLEODS PHARMACEUTICALS LIMITED ($18.5M), LUPIN LIMITED ($18.4M). Medwise Overseas Private Limited processed 15 shipments to 4 destination countries.
What Rifampicin Formulations Does Medwise Overseas Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RIFAMPICIN 150 MG + ISONIAZIDE 75 MG (BA | $100.0K | 2 |
| RISOTOL WISE (RIFAMPICIN 150 MG + ISONIA | $100.0K | 2 |
| RIFAMPICIN 150MG+ISONIAZID 75MG+PYRAZINA | $94.6K | 2 |
| RISOTOLWISE-4(RIFAMPICIN 150 MG+ISONIAZI | $50.0K | 1 |
| RISOTOLWISE (RIFAMPICIN 150 MG + ISONIAZ | $28.4K | 1 |
| RIFAMPICIN 75 MG + ISONIAZID 50 MG (BATC | $28.2K | 2 |
| RIFAMPICIN 150 MG + ISONIAZID 75 MG TABL | $11.1K | 1 |
| RIFAMPICIN 150 MG + ISONIAZID 75 MGBATC | $8.1K | 1 |
| RISOTOLWISE-4 RIFAMPICIN 150 MG+ISONIAZ | $4.9K | 1 |
| RIFAMPICIN 75 MG + ISONIAZID 50 MG + PYR | $2.9K | 2 |
Medwise Overseas Private Limited exports 10 distinct Rifampicin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RIFAMPICIN 150 MG + ISONIAZIDE 75 MG (BA with 2 shipments worth $100.0K.
Regulatory Requirements: Exporting Rifampicin to Key Markets
What Medwise Overseas Private Limited must comply with to export Rifampicin to its top destination countries
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Medwise Overseas Private Limited Compare to Nearest Rifampicin Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | MANEESH PHARMACEUTICALS LTD | $850.0K | 17 | 7 | $50.0K |
| 10 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED | $803.7K | 24 | 2 | $33.5K |
| 9 | MEDWISE OVERSEAS PRIVATE LIMITED ★ | $750.0K | 15 | 4 | $50.0K |
| 11 | UNILINK PHARMA PRIVATE LIMITED | $400.0K | 8 | 2 | $50.0K |
| 12 | CENTURION LABORATORIES PRIVATE LIMITED | $250.0K | 5 | 1 | $50.0K |
Medwise Overseas Private Limited ranks #9 among 175 Indian Rifampicin exporters. Average shipment value of $50.0K compared to the market average of $696.0K. The closest competitors by value are MANEESH PHARMACEUTICALS LTD and COMBITIC GLOBAL CAPLET PRIVATE LIMITED.
Which Indian Ports Ship Rifampicin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 947 | 24.2% |
| SAHAR AIR | 813 | 20.8% |
| DELHI AIR CARGO ACC (INDEL4) | 477 | 12.2% |
| DELHI AIR | 404 | 10.3% |
| NHAVA SHEVA SEA (INNSA1) | 295 | 7.5% |
| Bombay Air | 175 | 4.5% |
| JNPT/ NHAVA SHEVA SEA | 116 | 3.0% |
| JNPT | 99 | 2.5% |
About Medwise Overseas Private Limited
Medwise Overseas Private Limited exports 19 products worth $4.4M. Beyond Rifampicin, top products include Nifedipine, Immunoglobulin, Isoniazid, Amiodarone, Morphine. View the complete Medwise Overseas Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rifampicin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rifampicin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medwise Overseas Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 15 individual customs records matching Medwise Overseas Private Limited exporting Rifampicin, covering 10 formulations to 4 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 162+ countries, 780+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rifampicin Export Data from Medwise Overseas Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medwise Overseas Private Limited's Rifampicin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medwise Overseas Private Limited
Full Company Profile →
19 products · $4.4M total trade · 10 categories
Rifampicin Stats
Company Overview
Top Products by Medwise Overseas Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medwise Overseas Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rifampicin. For current shipment-level data, contact TransData Nexus.